Fractyl Health
Develops endoscopic and gene therapies that target root causes of obesity and type 2 diabetes
Highlights
- New on EvolcAdded 2026-11-11
About Fractyl Health
Fractyl Health develops therapies for obesity and type 2 diabetes that target the duodenum and pancreas. Revita is an outpatient endoscopic procedure designed to resurface the duodenal lining; it is investigational in the US and its REMAIN-1 pivotal study met the six-month co-primary endpoint. Rejuva is a one-time gene therapy platform designed to target pancreatic islet cells and is in early development.
The therapies are aimed at people with obesity and type 2 diabetes. The company's stated goal is to move treatment from chronic symptomatic management to durable, disease-modifying therapies.
Harith Rajagopalan is co-founder, President and CEO. The management team includes a CFO, a General Counsel and senior leaders in regulatory, market access and manufacturing. The company lists a general application opening for Burlington, Massachusetts.
Product: Revita, an outpatient endoscopic duodenal resurfacing procedure (investigational in the US); Rejuva, a one-time gene therapy platform for pancreatic islet cells in early development.
Jobs at Fractyl Health
More biotech & pharma companies
Gatesfoundation
Non-profit developing drugs, biologics and vaccines for tuberculosis and malaria in low- and middle-income countriesGilead
Develops CAR T-cell therapies and other cell therapy treatments for people with cancerGilead
Biopharmaceutical company developing and delivering therapies for serious diseases, including virology, oncology and inflammation treatmentsHAYA Therapeutics
Develops RNA-guided medicines that target non-coding RNAs in disease, with Eli Lilly as a collaboration partnerIambic Therapeutics
AI-enabled drug discovery and development for pharmaceutical and biotechnology partnersRemote-friendlyIllumina
DNA sequencing, microarray and genomics software for researchers, clinicians and laboratoriesRemote-friendlySalary transparent
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- CookieYesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- GreenhouseMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.